CMOPF Stock Price, Chart, Stats & News

Cosmo Pharmaceuticals N.V. (CMOPF) is a dividend-paying stock with a current dividend yield of 6.56% as of Aug 13, 2026. It pays $4.93 per share over the trailing twelve months and distributes bi-annually.
CMOPF chart
About
Cosmo Pharmaceuticals N. V., a life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral tablet formulation that delivers budesonide directly to the lumen of the colon; Eleview, an injectable composition to allow endoscopists with excision of gastrointestinal lesions; Lumeblue, a diagnostic drug for the visualisation of colorectal lesions during colonoscopies; Aemcolo/Rifamycin, a pharmaceutical drug product in form of tablets that is approved for the treatment of travelers' diarrhoea; and Clascoterone, which is in phase-3 clinical trial for the treatment of male pattern hair loss.
Related lists
Similar securities
Based on sector and market capitalization





